AzA administration reduced plasma glucose, insulin, liver glycogen and key carbohydrate metabolic enzymes in HFD-induced type 2 diabetic mice (Litvinov et al., 2010; Muthulakshmi and Saravanan, 2013). This evidence concerns the gene INS and type 2 diabetes mellitus.